Platelet-related indices in patients with lung cancer with nivolumab

Platelet-related indices in patients with lung cancer with nivolumab

Bibliographic Details
Main Authors:	Shosaku Nomura, Takashi Yokoi, Takayasu Kurata
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-02-01
Series:	Platelets
Online Access:	http://dx.doi.org/10.1080/09537104.2017.1356454

Similar Items

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer
by: Yuki Nakatani, et al.
Published: (2017-08-01)

Spatial and temporal genetic heterogeneity of epidermal growth factor receptor gene status in a patient with non-small cell lung cancer: a case report
by: Ogata Makoto, et al.
Published: (2011-11-01)

New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
by: Niki M, et al.
Published: (2017-08-01)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017-05-01)

Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report
by: Takashi Sakai, et al.
Published: (2019-01-01)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
by: Zhou S, et al.
Published: (2019-01-01)

Bullous pemphigoid in a metastatic lung cancer patient associated with nivolumab
by: Yuka Maya, MD, et al.
Published: (2020-12-01)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
by: Hidetoshi Hayashi, et al.
Published: (2011-01-01)

Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient
by: Susumu Noguchi, et al.
Published: (2018-08-01)

Autonomic enteric neuropathy following nivolumab monotherapy in a patient with Lung Cancer
by: Stephanie Andrews, et al.
Published: (2020-12-01)

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer
by: Masahiro Yamasaki, et al.
Published: (2017-04-01)

Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer
by: Hidenori Mori, et al.
Published: (2019-01-01)

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial
by: Hua Ye, et al.
Published: (2021-04-01)

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
by: Margaux Geier, et al.
Published: (2020-10-01)

Platelet indices in patients with colorectal cancer
by: Karagöz Bülent, et al.
Published: (2010-06-01)

Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
by: Shunji Endo, et al.
Published: (2020-10-01)

Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review
by: Marta Dudzińska, et al.
Published: (2020-08-01)

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab
by: Jessica Cusato, et al.
Published: (2019-01-01)

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
by: Yuki Nakatani, et al.
Published: (2018-12-01)

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
by: Andrea Botticelli, et al.
Published: (2019-03-01)

A case of nivolumab-induced hypopituitarism in a head and neck cancer patient
by: Mioko Matsuo, et al.
Published: (2020-03-01)

Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer
by: Kenji Takada, et al.
Published: (2021-06-01)

Advances in Diagnosis and Treatments for Immune Thrombocytopenia
by: Shosaku Nomura
Published: (2016-01-01)

Advances in Diagnosis and Treatments for Immune Thrombocytopenia
by: Shosaku Nomura
Published: (2016-07-01)

Platelets count and platelets indices; mean platelet volume and plateletcrit in pediatric chronic lung disease
by: Iman H. Draz, et al.
Published: (2020-03-01)

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report
by: Eriko Fujimoto, et al.
Published: (2018-05-01)

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease
by: Hiroaki Satoh, et al.
Published: (2022-06-01)

Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients
by: Magri V, et al.
Published: (2019-09-01)

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases
by: Masahiro Yamasaki, et al.
Published: (2019-01-01)

Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer
by: James Luke Godwin, et al.
Published: (2017-05-01)

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
by: Saori Mishima, et al.
Published: (2019-01-01)

Efficacy of gefapixant, a P2X antagonist, for lung cancer-related cough: a case report
by: Yoshihisa Ishiura, et al.
Published: (2023-08-01)

Results of combined nivolumab and ipilimumab therapy in patients with cancer
by: M. A. Lyadova, et al.
Published: (2021-12-01)

Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey
by: Hiroki Hata MS, et al.
Published: (2020-12-01)

Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma
by: Naoki Furuya, et al.
Published: (2020-11-01)

Neoadjuvant nivolumab with chemotherapy: a miraculous new regime in treatment of resectable lung cancers
by: Nisha Babar, et al.
Published: (2022-12-01)

Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer
by: Christopher R. Dermarkarian, MD, et al.
Published: (2020-06-01)

Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
by: Takuma Imakita, et al.
Published: (2017-01-01)

An autopsy case of immune-related severe colitis due to long-term use of nivolumab in a patient with non-small cell lung cancer
by: Masashi Fujikawa, et al.
Published: (2022-01-01)

Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generating study
by: Hiroshi Soda, et al.
Published: (2019-02-01)